0
0

Justice for Vaccine Victims Act of 2022

12/29/2022, 10:18 PM

Summary of Bill HR 7308

Bill 117 hr 7308, also known as the Justice for Vaccine Victims Act of 2022, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to provide compensation and support for individuals who have experienced adverse reactions to vaccines.

The bill establishes a Vaccine Injury Compensation Program, which would provide financial assistance to individuals who have been injured by vaccines. This program would be funded by a small fee on each vaccine dose administered in the United States.

In order to be eligible for compensation under this program, individuals would need to demonstrate that they have experienced a serious adverse reaction to a vaccine. The bill also includes provisions for the establishment of a Vaccine Injury Compensation Board, which would review and adjudicate claims for compensation. Overall, the Justice for Vaccine Victims Act of 2022 aims to provide support and assistance to individuals who have been harmed by vaccines, while also ensuring that the vaccine supply in the United States remains safe and effective.

Congressional Summary of HR 7308

Justice for Vaccine Victims Act of 2022

This bill terminates the COVID-19 emergency and requires an investigation into adverse events associated with a COVID-19 vaccination. The bill also repeals federal income tax deductions for certain state, local, and foreign taxes paid by an individual.

The Department of Health and Human Services (HHS) must terminate the COVID-19 emergency within three months of the bill's enactment. The bill also removes, within three months of that termination, liability protections that apply to the administration or use of certain medical countermeasures (e.g., vaccines) during the public health emergency.

Additionally, the HHS Office of Inspector General must investigate adverse events associated with a COVID-19 vaccine that are reported to the Vaccine Adverse Event Reporting System. In carrying out the investigation, the office must ask specified questions of (1) each individual (or the individual's survivors) who reported an adverse event, (2) each manufacturer of a COVID-19 vaccine distributed in the United States, and (3) a sample of health care providers. The office must report its findings and recommendations, and the report must include, among other matters, transcripts of all interviews with individuals, manufacturers, and health care providers. The office must also report on the costs of carrying out this investigation.

Current Status of Bill HR 7308

Bill HR 7308 is currently in the status of Bill Introduced since April 5, 2022. Bill HR 7308 was introduced during Congress 117 and was introduced to the House on March 31, 2022.  Bill HR 7308's most recent activity was Sponsor introductory remarks on measure. (CR H4158) as of April 5, 2022

Bipartisan Support of Bill HR 7308

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
0
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7308

Primary Policy Focus

Health

Potential Impact Areas

- Allergies
- Business records
- Cardiovascular and respiratory health
- Civil actions and liability
- Congressional oversight
- Consumer affairs
- Emergency medical services and trauma care
- Evidence and witnesses
- Government information and archives
- Government studies and investigations
- Health facilities and institutions
- Health information and medical records
- Health personnel
- Health technology, devices, supplies
- Immunology and vaccination
- Infectious and parasitic diseases
- Manufacturing
- Product safety and quality

Alternate Title(s) of Bill HR 7308

Justice for Vaccine Victims Act of 2022
Justice for Vaccine Victims Act of 2022
To direct the Inspector General of the Department of Health and Human Services to investigate and report on the Vaccine Adverse Event Reporting System, and for other purposes.

Comments